Zobrazeno 31 - 40
of 30 611
pro vyhledávání: ''
Publikováno v:
ACTUAL INFECTOLOGY. :171-176
Introduction. Mixed cryoglobulinemia is the most common extrahepatic manifestations of chronic HCV-infection. Questions about the role of cytokines and features of liver injury in patients with chronic HCV-infection with mixed cryoglobulinemia are de
Pseudo Heparin Resistance After Pulmonary Endarterectomy: Role of Thrombus Production of Factor VIII
Autor:
Yidan Zhao, Marc de Perrot, Usman M. Asghar, Rita Selby, Laura Donahoe, John Granton, Karen McRae, A.I. Nykanen
Publikováno v:
Seminars in Thoracic and Cardiovascular Surgery. 34:315-323
Pulmonary endarterectomy (PEA) is the main treatment for chronic thromboembolic pulmonary hypertension (CTEPH). Postoperative unfractionated heparin dosing can be monitored by activated partial thromboplastin time (APTT) or by anti-factor Xa activity
Autor:
Emina Sudar-Milovanovic, Esma R. Isenovic, Dragan Stajic, Milan Obradovic, Bojan Mitrovic, Djuro Macut, Zoran Gluvic, Sanja Soskic
Publikováno v:
Endocrine, Metabolic & Immune Disorders - Drug Targets. 22:117-124
Background and Objectives : Non-alcoholic fatty liver disease (NAFLD) is associated with inflammation and subsequent increase in cardiovascular risk. Because of its widespread presence and distribution, invasive diagnostic procedures (i.e., liver bio
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Publikováno v:
Diabetes & Metabolism Journal, Vol 46, Iss 1, Pp 63-70 (2022)
Background: It is not known which type 2 diabetes mellitus (T2DM) patients would most benefit from dipeptidyl peptidase-4 (DPP-4) inhibitor treatment. We aimed to investigate the predictors of response to DPP-4 inhibitors considering degree of DPP-4
Autor:
Harsh Vardhan Tevethia, Mukesh Ranjan, Siew C. Ng, Rakesh Kochhar, Kirandeep Kaur, Govind K. Makharia, Ajit Sood, Vandana Midha, Stephen B. Hanauer, C. Ganesh Pai, Charles N. Bernstein, Abhinav Anand, Suhang Verma, Joyce Wing Yan Mak, Rupa Banerjee, Saurabh Kedia, Kiran Peddi, Amit Kumar Dutta, Vineet Ahuja, Varun Mehta, Ramit Mahajan, Saroj K. Sinha, Perttu Arkkila, Usha Dutta, Arshdeep Singh, Devendra Desai
Publikováno v:
Intestinal Research, Vol 20, Iss 1, Pp 11-30 (2022)
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD has come under the spotlight. 5-Aminosalicylates, corticosteroids
Autor:
Michail Doukas, Merel van Pieterson, Sarah T A Teklenburg-Roord, Herbert M. van Wering, Lissy de Ridder, Dimitris Rizopoulos, Martinus A. Cozijnsen, Maria M E Jongsma, Obbe F. Norbruis, Michiel P. van Wijk, Marco W.J. Schreurs, Thalia Hummel, Johanna C. Escher, Janneke M. Stapelbroek, Michael Groeneweg, Kaija-Leena Kolho, Cathelijne van der Feen, Iva Hojsak, Tim G. J. de Meij, Janneke N. Samsom, M Aardoom, Victorien M. Wolters, Patrick F. van Rheenen
Publikováno v:
Jongsma, M M E, Aardoom, M A, Cozijnsen, M A, van Pieterson, M, de Meij, T, Groeneweg, M, Norbruis, O F, Wolters, V M, van Wering, H M, Hojsak, I, Kolho, K-L, Hummel, T, Stapelbroek, J, van der Feen, C, van Rheenen, P F, van Wijk, M P, Teklenburg-Roord, S T A, Schreurs, M W J, Rizopoulos, D, Doukas, M, Escher, J C, Samsom, J N & de Ridder, L 2022, ' First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: An open-label multicentre randomised controlled trial ', Gut, vol. 71, no. 1, pp. 34-42 . https://doi.org/10.1136/gutjnl-2020-322339
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
Gut, 71(1), 34-42. BMJ Publishing Group
Gut, 71, 34-42. BMJ PUBLISHING GROUP
ObjectiveIn newly diagnosed paediatric patients with moderate-to-severe Crohn’s disease (CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and immunomodulator therapies have failed. We aimed to investigate wh
Autor:
Rafael Sartori Balbinot, Silvana Sartori Balbinot, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Ana Laura Facco Muscope, Bruna Schena, Morgana Luisa Longen, Alana Zulian Terres, Jonathan Soldera, Bruna Teston Cini
Publikováno v:
Gastroenterología y Hepatología. 45:25-39
Hepatorenal syndrome (HRS) is the deadliest complication of cirrhosis. The purpose of this study is to analyze if the use of a protocol for HRS is associated with higher survival in these patients.An evidence-based protocol for the diagnosis and trea
Autor:
Alicia Probst, Emilie De Carli, Isabelle Aerts, Pascal Chastagner, Natacha Entz-Werle, Caroline Solas, Anne-Isabelle Bertozzi-Salamon, Nicolas André, Anne Pagnier, Emmanuelle Tresch-Bruneel, Pierre Leblond, Jacques Grill, Didier Frappaz, Mourad Hamimed, Florence Gattacceca
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, 2021, ⟨10.1111/bcp.15131⟩
British Journal of Clinical Pharmacology, Wiley, 2021, ⟨10.1111/bcp.15131⟩
AIM There is a crucial need for pharmacokinetic (PK) data of oral vinorelbine (VNR) in pediatric population. The aim of this work was to assess the PK profile of orally administered VNR in children with recurrent/progressive primary low-grade glioma
Publikováno v:
Gastroenterología y Hepatología. 44:671-679
Resumen Objetivo Estudiar las caracteristicas epidemiologicas, clinicas y la respuesta al tratamiento en pacientes con colitis microscopica. Pacientes y metodo Se recopilaron retrospectivamente los datos epidemiologicos, clinicos, analiticos y endosc